Hematogenix Announces the Availability of COVID-19 Antibody Testing

Hematogenix Announces the Availability of COVID-19 Antibody Testing

 


 

Hematogenix Adds Myeloid Genotyping to its Menu of Genomic Testing

Hematogenix Adds Myeloid Genotyping to its Menu of Genomic Testing


 

China Expansion Press Release

Hematogenix Announces the Opening of Their Newest Facility in Shanghai, China


 PD-L1 Press Release

Hematogenix Laboratory Services, LLC Introduces the Availability of PD-L1 Companion Diagnostic Tests


THxID®-BRAF Press Release

Hematogenix Laboratory Services to Offer FDA Approved THxID®‐BRAF Companion Diagnostic Testing Services in the US


RNAscope®-ISH Press Release 

Hematogenix Laboratory Services – The First Diagnostic Testing and CLIA-Certified Biomarker Services Laboratory to Offer Advanced Cell Diagnostics, RNAscope® Assays to Clients


New Test Offering - MRD-CLL

Hematogenix Laboratory Services Launches Minimal Residual Disease (MRD) Evaluation for Chronic Lymphocytic Leukemia (CLL) Using the Standardized ERIC Method


Hematogenix Launches FDA Approved Companion Diagnostic Immuno-oncology Test for Triple-Negative Breast Cancer

Hematogenix Launches FDA Approved Companion Diagnostic Immuno-oncology Test for Triple-Negative Breast Cancer